Medicare Enrolled
Dr. David Gallinson, D.O.
Hematology & Oncology · Livingston, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gallinson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gallinson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gallinson
Dr. David Gallinson is a hematology & oncology specialist in Livingston, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gallinson performed 6,418 Medicare services across 2,362 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gallinson received a total of $17,081 from 26 pharmaceutical and/or device companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gallinson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 35% volume in NJ
$17,081 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,418
Medicare services
Top 35% in NJ for hematology & oncology
2,362
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~321 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,267 | $8 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,261 | $8 | $15 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
887 | $10 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
546 | $157 | $366 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $103 | $274 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
236 | $13 | $56 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
216 | $0 | $2 |
| Iron level test | 193 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
193 | $8 | $36 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
153 | $9 | $38 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
132 | $7 | $28 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
112 | $4 | $19 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
90 | $6 | $25 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
89 | $101 | $256 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
87 | $5 | $20 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
70 | $16 | $52 |
| New patient office visit, complex (60-74 min) | 61 | $193 | $516 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
53 | $4 | $17 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
42 | $10 | $36 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $68 | $179 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $143 | $497 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
36 | $14 | $103 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
31 | $16 | $69 |
| PSA test (prostate cancer screening) | 26 | $15 | $76 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
25 | $14 | $62 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
25 | $21 | $75 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
21 | $114 | $597 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
18 | $11 | $72 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
13 | $13 | $55 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
4.2% medium
95.5% routine
Industry Payment Transparency
Open Payments through 2023 ↗$17,081
Total received (2018-2023)
Avg $2,847/year across 6 years
Top 18% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
82
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,985 (70.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,899 (17.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,196 (12.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$5,742
2022
$2,388
2021
$1,073
2020
$3,166
2019
$490
2018
$4,221
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
ARRAY BIOPHARMA INC
$2,520
BeiGene USA, Inc.
$2,250
Bayer Healthcare Pharmaceuticals Inc.
$750
AstraZeneca Pharmaceuticals LP
$120
Incyte Corporation
$102
Top 3 companies account for 96.1% of 2023 payments
All-time payments by company (2018-2023) ›
ARRAY BIOPHARMA INC
$4,410
Gilead Sciences, Inc.
$3,560
BeiGene USA, Inc.
$2,250
Incyte Corporation
$1,905
Bayer HealthCare Pharmaceuticals Inc.
$1,034
Sirtex Medical Inc
$983
Bayer Healthcare Pharmaceuticals Inc.
$750
AstraZeneca Pharmaceuticals LP
$589
BeiGene, Ltd.
$450
Seagen Inc.
$339
Genentech USA, Inc.
$181
E.R. Squibb & Sons, L.L.C.
$148
Novartis Pharmaceuticals Corporation
$71
Exelixis Inc.
$70
Agios Pharmaceuticals, Inc.
$56
Lilly USA, LLC
$43
Merck Sharp & Dohme Corporation
$37
Takeda Pharmaceuticals U.S.A., Inc.
$35
Astellas Pharma US Inc
$30
Verastem, Inc.
$28
EMD Serono, Inc.
$26
PFIZER INC.
$26
Seattle Genetics, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$15
EISAI INC.
$15
GENZYME CORPORATION
$15
Top 3 companies account for 59.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Avastin · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · CYRAMZA · Cabometyx · Copiktra · ELIQUIS · GAZYVA · IMFINZI · KEYTRUDA · KISQALI · LARTRUVO · LIBTAYO · Lenvima · MONJUVI · NINLARO · Nubeqa · OPDIVO · PADCEV · REBLOZYL · SIR-Spheres Microspheres · Stivarga · TAGRISSO · TASIGNA · TIBSOVO · TUKYSA · VERZENIO · Vitrakvi · XOSPATA · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
615
Per 100K population
72.0
County median income
$76,712
Nearest hospital
COOPERMAN BARNABAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gallinson is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 18% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gallinson experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Gallinson performed 1,267 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gallinson receive payments from pharmaceutical companies?
Yes. Dr. Gallinson received a total of $17,081 from 26 companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gallinson's costs compare to other hematology & oncology specialists in Livingston?
Dr. Gallinson's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gallinson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Livingston
Browse hematology & oncology specialists in Livingston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
ARRAY BIOPHARMA INC Payments to Doctors
See all physicians who received payments from ARRAY BIOPHARMA INC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology